PIRAFAVI 200 MG 20 F.C.TABS

FAVIPIRAVIR TRIPHOSPHATE IS A PURINE NUCLEOSIDE ANALOGUE WHICH ACTS AS A COMPETITIVE INHIBITOR OF RNA-DEPENDENT RNA POLYMERASE. NOT ONLY DOES FAVIPIRAVIR INHIBIT REPLICATION OF INFLUENZA A AND B BUT THE DRUG HAS SHOWN PROMISE IN THE TREATMENT OF AVIAN INFLUENZA AND MAY BE AN ALTERNATIVE OPTION FOR INFLUENZA STRAINS THAT ARE RESISTANT TO NEURAMIDASE INHIBITORS. FAVIPIRAVIR HAS BEEN INVESTIGATED FOR THE TREATMENT OF LIFE-THREATENING PATHOGENS SUCH AS EBOLA VIRUS LASSA VIRUS AND NOW COVID-19.